Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 269

1.

Antiretroviral resistance following first-line antiretroviral therapy failure in diverse HIV-1 subtypes clades in the SECOND-LINE study.

Lam EP, Moore CL, Gotuzzo E, Nwizu C, Kamarulzaman AB, Chetchotisakd P, van Wyk J, Teppler H, Kumarasamy N, Molina JM, Emery S, Cooper DA, Boyd MA.

AIDS Res Hum Retroviruses. 2016 Jun 26. [Epub ahead of print]

PMID:
27346600
2.

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale.

Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, Jakait B, Maina M, Yotebieng M, Kumarasamy N, Freeman A, de Rekeneire N, Duda SN, Davies MA, Braitstein P.

Drug Saf. 2016 Jun 9. [Epub ahead of print]

PMID:
27282427
3.

Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.

Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Mbchb, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A; New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) study teams.

J Acquir Immune Defic Syndr. 2016 May 27. [Epub ahead of print]

PMID:
27258230
4.

Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.

La Rosa AM, Harrison LJ, Taiwo B, Wallis CL, Zheng L, Kim P, Kumarasamy N, Hosseinipour MC, Jarocki B, Mellors JW, Collier AC; ACTG A5273 Study Group.

Lancet HIV. 2016 Jun;3(6):e247-58. doi: 10.1016/S2352-3018(16)30011-X. Epub 2016 Apr 18.

PMID:
27240787
5.

The impact of antiretroviral therapy in resource-limited settings and current HIV therapeutics.

Kumarasamy N.

Oral Dis. 2016 Apr;22 Suppl 1:42-5. doi: 10.1111/odi.12458.

PMID:
27109271
6.

The social impact of HIV/AIDS in India.

Solomon S, Kumarasamy N, Challacombe SJ.

Oral Dis. 2016 Apr;22 Suppl 1:15-8. doi: 10.1111/odi.12449.

PMID:
27109268
7.

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team.

Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8.

PMID:
27025337
8.

Perspectives of Mobile Versus Fixed Mammography in Santa Clara County, California: A Focus Group Study.

Chen YR, Chang-Halpenny C, Kumarasamy NA, Venegas A, Braddock Iii CH.

Cureus. 2016 Feb 12;8(2):e494. doi: 10.7759/cureus.494.

9.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study Team.

J Infect Dis. 2016 Jul 1;214(1):65-72. doi: 10.1093/infdis/jiw096. Epub 2016 Mar 8.

PMID:
26962236
10.

Improved survival in HIV treatment programmes in Asia.

De La Mata NL, Kumarasamy N, Khol V, Ng OT, Van Nguyen K, Merati TP, Pham TT, Lee MP, Durier N, Law M.

Antivir Ther. 2016 Feb 10. doi: 10.3851/IMP3041. [Epub ahead of print]

PMID:
26961354
11.

Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.

Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD).

Trop Med Int Health. 2016 May;21(5):662-74. doi: 10.1111/tmi.12690. Epub 2016 Mar 29.

PMID:
26950901
12.

Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.

Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.

PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016.

13.

Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).

Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL.

J Antimicrob Chemother. 2016 Jun;71(6):1609-18. doi: 10.1093/jac/dkw005. Epub 2016 Feb 17.

PMID:
26892777
14.

Suniti Solomon, Founder-Director Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE).

Kumarasamy N, Ranganathan K, Tappuni AR, Challacombe SJ.

Oral Dis. 2016 Apr;22 Suppl 1:8-9. doi: 10.1111/odi.12425. Epub 2016 Feb 16. No abstract available.

PMID:
26881420
15.

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9. doi: 10.1097/QAI.0000000000000951.

PMID:
26859828
16.

Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia.

Boettiger DC, Aurpibul L, Hudaya DM, Fong SM, Lumbiganon P, Saphonn V, Truong KH, Hansudewechakul R, Nguyen LV, Do VC, Bunupuradah T, Chokephaibulkit K, Nik Yusoff NK, Kumarasamy N, Wati DK, Razali KA, Kariminia A; TREAT Asia Pediatric HIV Observational Database.

Pediatr Infect Dis J. 2016 May;35(5):e144-51. doi: 10.1097/INF.0000000000001074.

PMID:
26835972
17.

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.

Kumarasamy N, Poongulali S, Bollaerts A, Moris P, Beulah FE, Ayuk LN, Demoitié MA, Jongert E, Ofori-Anyinam O.

Medicine (Baltimore). 2016 Jan;95(3):e2459. doi: 10.1097/MD.0000000000002459.

18.

Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.

Boettiger DC, Sudjaritruk T, Nallusamy R, Lumbiganon P, Rungmaitree S, Hansudewechakul R, Kumarasamy N, Bunupuradah T, Saphonn V, Truong KH, Yusoff NK, Do VC, Nguyen LV, Razali KA, Fong SM, Kurniati N, Kariminia A.

J Adolesc Health. 2016 Apr;58(4):451-9. doi: 10.1016/j.jadohealth.2015.11.006. Epub 2016 Jan 20.

PMID:
26803201
19.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J; With the 5271 study team, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A; AIDS Clinical Trials Group.

J Neurovirol. 2016 Jan 5. [Epub ahead of print]

PMID:
26733457
20.

Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207.

Hitti J, Halvas EK, Zheng L, Panousis CG, Kabanda J, Taulo F, Kumarasamy N, Pape JW, Lalloo U, Sprenger H, Klingman KL, Chan ES, McMahon D, Mellors JW.

J AIDS Clin Res. 2014 Nov;5(11). pii: 371. Epub 2014 Nov 9.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk